Abstract
The prevalence of Addison’s disease in South Africa is lower than in Western countries. This is concerning, since patients could be dying, undiagnosed. Enhanced awareness of this highly treatable condition is warranted. The epidemiology, aetiology, clinical presentation, screening and management of Addison’s disease are discussed. Autoimmunity predominated as the underlying aetiology mostly in patients of European descent. A low threshold is required for screening, intervention and follow-up of all patients for cardiovascular risk factors, given the atherogenic profile observed among Addison’s disease sufferers in South Africa.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Endocrinology, Metabolism and Diabetes of South Africa
Paper Title
Journal
Date
